Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Enable Biosciences in August, 2018 for $223,806.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI141118-01 | Phase I | 223,806 | August 8, 2018 | |||||||
A SBIR Phase I contract was awarded to Enable Biosciences in March, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI142936-01 | Phase I | 225,000 | March 11, 2019 | |||||||
A SBIR Phase II contract was awarded to Enable Biosciences in September, 2019 for $746,584.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK124009-01 | Phase II | 746,584 | September 19, 2019 | |||||||
A SBIR Phase II contract was awarded to Enable Biosciences in April, 2018 for $1,499,676.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK111005-02 | Phase II | 1,499,676 | April 20, 2018 | |||||||
A SBIR Phase II contract was awarded to Enable Biosciences in April, 2020 for $845,777.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI141118-02 | Phase II | 845,777 | April 6, 2020 | |||||||
A SBIR Phase I contract was awarded to Enable Biosciences in August, 2016 for $224,423.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK111005-01 | Phase I | 224,423 | August 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Enable Biosciences in March, 2018 for $750,000.0 USD from the National Science Foundation. | SBIR | 1758698 | Phase II | 750,000 | March 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Enable Biosciences in July, 2016 for $224,811.0 USD from the National Science Foundation. | SBIR | 1622257 | Phase I | 224,811 | July 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Enable Biosciences in June, 2023 for $990,010.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK111005-04 | Phase II | 990,010 | June 1, 2023 |